Cargando…
Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020913/ https://www.ncbi.nlm.nih.gov/pubmed/32103906 http://dx.doi.org/10.2147/PPA.S236468 |
_version_ | 1783497833674964992 |
---|---|
author | Murdoch, Ian Nyakundi, David Baker, Helen Dulku, Simon Kiage, Daniel |
author_facet | Murdoch, Ian Nyakundi, David Baker, Helen Dulku, Simon Kiage, Daniel |
author_sort | Murdoch, Ian |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received a weighed bottle of Lumigan 0.01% with counselling on therapy. The bottles were returned monthly for renewal and weighed on return to estimate drops taken during the period. Data collection was for one year with a short compliance questionnaire. RESULTS: 11 patients participated. 5 (45%) failed to complete one full year of topical therapy. The overall mean number of drops per eye per day was 1.74 (SD 0.69) for the 6 with one year of monthly returned bottles and controlled IOPs at each visit. Self-perception of compliance in these patients was good. CONCLUSION: The signs of poor adherence based on both self-report (previous literature), and in this small-scale study of an objective measure suggest medication may not be the first-line treatment of choice in this environment. Our report does, however, raise the possibility that those patients who return for repeat prescriptions and review are indeed adhering to their treatment regimens. |
format | Online Article Text |
id | pubmed-7020913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70209132020-02-26 Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study Murdoch, Ian Nyakundi, David Baker, Helen Dulku, Simon Kiage, Daniel Patient Prefer Adherence Original Research BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received a weighed bottle of Lumigan 0.01% with counselling on therapy. The bottles were returned monthly for renewal and weighed on return to estimate drops taken during the period. Data collection was for one year with a short compliance questionnaire. RESULTS: 11 patients participated. 5 (45%) failed to complete one full year of topical therapy. The overall mean number of drops per eye per day was 1.74 (SD 0.69) for the 6 with one year of monthly returned bottles and controlled IOPs at each visit. Self-perception of compliance in these patients was good. CONCLUSION: The signs of poor adherence based on both self-report (previous literature), and in this small-scale study of an objective measure suggest medication may not be the first-line treatment of choice in this environment. Our report does, however, raise the possibility that those patients who return for repeat prescriptions and review are indeed adhering to their treatment regimens. Dove 2020-02-10 /pmc/articles/PMC7020913/ /pubmed/32103906 http://dx.doi.org/10.2147/PPA.S236468 Text en © 2020 Murdoch et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Murdoch, Ian Nyakundi, David Baker, Helen Dulku, Simon Kiage, Daniel Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title | Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title_full | Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title_fullStr | Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title_full_unstemmed | Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title_short | Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study |
title_sort | adherence with medical therapy for primary open-angle glaucoma in kenya – a pilot study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020913/ https://www.ncbi.nlm.nih.gov/pubmed/32103906 http://dx.doi.org/10.2147/PPA.S236468 |
work_keys_str_mv | AT murdochian adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy AT nyakundidavid adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy AT bakerhelen adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy AT dulkusimon adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy AT kiagedaniel adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy |